Neuronal conditions of spinal cord in dermatitis are improved by olopatadine

European Journal of Pharmacology

Volumn 547, Issue 1-3, 2006, Pages 45-51

  Hamada, Rie ^a   Seike, Masahiro ^a,b   Kamijima, Reiko ^a   Ikeda, Mitsunori ^a   Kodama, Hajime ^a   Ohtsu, Hiroshi ^c  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

c Fos; Contact dermatitis; Eczematous lesion; Olopatadine hydrochloride; Substance P

Indexed keywords

CETIRIZINE; CHLORPHENIRAMINE MALEATE; DIPHENCYPRONE; FEXOFENADINE; OLOPATADINE; PROTEIN C FOS; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ECZEMA; FEMALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCRATCHING; SENSORY NERVE; SKIN DEFECT; SKIN MANIFESTATION; SKIN STIMULATION; SPINAL CORD; SPINAL CORD DORSAL HORN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; CYCLOPROPANES; DERMATITIS, CONTACT; DIBENZOXEPINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECZEMA; FEMALE; HISTAMINE H1 ANTAGONISTS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; NEURONS; POSTERIOR HORN CELLS; PROTO-ONCOGENE PROTEINS C-FOS; PRURITUS; SKIN; SUBSTANCE P;

EID: 33748532503     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.058     Document Type: Article

References (50)

1. Advenier C., and Devillier P. Neurokinins and the skin. Allerg. Immunol. 25 (1993) 280-282
2. 4 of itch-associated response in mice. Soc. Neurosci. Abstr. 24 (1998) 1865
3. Arthur R.P., and Shelley W.B. The nature of itching in dermatitic skin. Ann. Intern. Med. 49 (1958) 900-908
4. Burton J.L., and Holden C.A. Eczema, Lichenification and Prurigo. In: Champion R.H., Burton J.L., Burns D.A., and Breathnach S.M. (Eds). Textbook of Dermatology. 6th edn. vol. 1 (1998), Blackwell Scientific Publications, Oxford 629-680
5. Cameron G.S., and Pence B.C. Effects of multiple applications of tumor promoters and ultraviolet radiation on epidermal proliferation and antioxidant status. J. Invest. Dermatol. 99 (1992) 189-192
6. Chan L.S., Robinson N., and Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J. Invest. Dermatol. 117 (2001) 977-983
7. Ghosh A.K., Hirasawa N., Ohtsu H., Watanabe T., and Ohuchi K. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 195 (2002) 973-982
8. Gibbs B.F., Wierecky J., Welker P., Henz B.M., Wolff H.H., and Grabbe J. Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp. Dermatol. 10 (2001) 312-320
9. Grossman R.M., Krueger J., Yourish D., Granelli-Piperno A., Murphy D.P., May L.T., Kupper T.S., Sehgal P.B., and Gottlieb A.B. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6367-6371
10. Hagermark O., Hokfelt T., and Pernow B. Flare and itch induced by substance P in human skin. J. Invest. Dermatol. 71 (1978) 233-235
11. Hayashi K., Kaise T., Ohmori K., Ishii A., and Karasawa A. Effects of olopatadine hydrochloride on the cutaneous vascular hyperpermeability and the scratching behavior induced by poly l-arginine in rats. Jpn. J. Pharmacol. 87 (2001) 167-170
12. Hirano T., Akira S., Taga T., and Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 11 (1990) 443-449
13. Hofstra C.L., Desai P.J., Thurmond R.L., and Fung-Leung W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305 (2003) 1212-1221
14. Holden C.A., and Parish W.E. Atopic dermatitis. In: Champion R.H., Burton J.L., Burns D.A., and Breathnach S.M. (Eds). Textbook of Dermatology. 6th edn. vol. 1 (1998), Blackwell Scientific Publications, Oxford 681-708
15. Horsmanheimo L., Harvima I.T., Jarvikallio A., Harrima R.J., Naukkarinen A., and Horsmanheimo M. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br. J. Dermatol. 131 (1994) 348-353
16. Hunt S.P., Pini A., and Evan G. Induction of c-Fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
17. Jarvikallio A., Naukkarinen A., Harvima I.T., Aalto M.L., and Horsmanheimo M. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br. J. Dermatol. 136 (1997) 871-877
18. Kayasuga R., Iba Y., Hossen M.A., Watanabe T., and Kamei C. The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice. Int. Immunopharmacol. 4 (2003) 469-473
19. Kohda F., Koga T., Uchi H., Urabe K., and Furue M. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes. J. Dermatol. Sci. 28 (2002) 34-41
20. Kupper T.S., Min K., Sehgal P.B., Mizutani H., Birchall N., Ray A., and May L. Product of IL-6 by keratinocytes: implications for epidermal inflammation and immunity. Ann. N.Y. Acad. Sci. 557 (1989) 454-464
21. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275 (1995) 229-233
22. Leung D.Y.M., Tharp M., and Boguniewicz M. Atopic dermatitis (Atopic eczema). In: Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., Katz S.I., and Fitzpatrick T.B. (Eds). Dermatology in General Medicine. 5th edn vol. 1 (1999), McGraw-Hill, New York 1473-1480
23. Makabe-Kobayashi Y., Hori Y., Adachi T., Ishigaki-Suzuki S., Kikuchi Y., Kagaya Y., Shirato K., Nagy A., Ujike A., Takai T., Watanabe T., and Ohtsu H. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J. Allergy Clin. Immunol. 110 (2002) 298-303
24. Mitchell E.B., Crow J., Williams G., and Platts-Mills T.A. Increase in skin mast cells following chronic house dust mite exposure. Br. J. Dermatol. 114 (1986) 65-73
25. Miyake K., Horikoshi K., Ikeda Y., Ishii A., and Karasawa A. Effects of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs. Jpn. J. Pharmacol. 85 (2001) 453-456
26. Morgan J.I., and Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14 (1991) 421-451
27. Nickoloff B.J., and Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 30 (1994) 535-546
28. Nikaein A., Phillips C., Gilbert S.C., Sarino D., Silverman A., Stone M.J., and Menter A. Characterization of skin-infiltrating lymphocytes in patients with psoriasis. J. Invest. Dermatol. 96 (1991) 3-9
29. Nojima H., Simons C.T., Cuellar J.M., Carstens M.I., Moore J.A., and Carstens E. Opioid modulation of scratching and spinal c-Fos expression evoked by intradermal serotonin. J. Neurosci. 23 (2003) 10784-10790
30. Nordlind K., Chin L.B., Ahmed A.A., Brakenhoff J., Theodorsson E., and Liden S. Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin. Arch. Dermatol. Res. 288 (1996) 431-435
31. Ohmori K., Hayashi K., Kaise T., Ohshima E., Kobayashi S., Yamazaki T., and Mukouyama A. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug. Jpn. J. Pharmacol. 88 (2002) 379-397
32. Ohshima E., Otaki S., Sato H., Kumazawa T., Obase H., Ishii A., Ishii H., Ohmori K., and Hirayama N. Synthesis and antiallergic activity of 11-(aminoalkylidene)-6, 11-dihydrodibenz[b, e]oxepin derivatives. J. Med. Chem. 35 (1992) 2074-2084
33. Ohtsu H., Kuramasu A., Tanaka S., Terui T., Hirasawa N., Hara M., Makabe-Kobayashi Y., Yamada N., Yanai K., Sakurai E., Okada M., Ohuchi K., Ichikawa A., Nagy A., and Watanabe T. Plasma extravasation induced by dietary supplemented histamine in histamine-free mice. Eur. J. Immunol. 32 (2002) 1698-1708
34. Rajka G. Itch duration in the uninvolved skin of atopic dermatitis (prurigo Besnier). Acta Derm.-Venereol., Suppl. (Stockh) 48 (1968) 320-321
35. Rexed B. The cytoarchitectonic organization of the spinal cord in the cat. J. Comp. Neurol. 96 (1952) 414-495
36. Ruzicka T., and Gluck S. Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE syndrome. Arch. Dermatol. Res. 275 (1983) 41-44
37. Schmelz M., Schmidt R., Weidner C., Hilliges M., Torebjork H.E., and Handwerker H.O. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J. Neurophysiol. 89 (2003) 2441-2448
38. Seike M., Ikeda M., Kodama H., Terui T., and Ohtsu H. Inhibition of scratching behaviour caused by contact dermatitis in histidine decarboxylase gene knockout mice. Exp. Dermatol. 14 (2005) 169-175
39. Seike M., Hamada R., Ikeda M., and Kodama H. Alteration of sensorineural circuits in spinal cord by chronic contact dermatitis. Somatosens. Motor Res. 22 (2005) 115-121
40. Seike M., Takata T., Ikeda M., Kodama H., Terui T., and Ohtsu H. Histamine helps development of eczematous lesions in experimental contact dermatitis in mice. Arch. Dermatol. Res. 297 (2005) 68-74
41. Shehab S.A., and Atkinson M.E. Vasoactive intestinal polypeptide increases in areas of the dorsal horn of the spinal cord from which other neuropeptides are depleted following peripheral axotomy. Exp. Brain Res. 62 (1986) 422-430
42. Stander S., Steinhoff M., Schmelz M., Weisshaar E., Metze D., and Luger T. Neurophysiology of pruritus. Cutaneous elicitation of itch. Arch. Dermatol. 139 (2003) 1463-1470
43. Tamura T., Matsubara M., and Takada C. Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice. Br. J. Dermatol. 151 (2004) 1133-1142
44. Tamura T., Amano T., Ohmori K., and Manabe H. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice. Eur. J. Pharmacol. 524 (2005) 149-154
45. Uchi H., Terao H., Koga T., and Furue M. Cytokines and chemokines in the epidermis. J. Dermatol. Sci. 24 suppl. 1 (2000) S29-S38
46. Wahlgren C.F., Tengvall L.M., Hagermark O., and Scheynius A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch. Dermatol. Res. 287 (1995) 572-580
47. Watanabe N., Matsuda E., Masuda A., Nariai K., and Shibasaki T. The effects of fexofenadine on eosinophilia and systemic anaphylaxis in mice infected with Trichinella spiralis. Int. Immunopharmacol. 4 (2004) 367-375
48. 2 receptors in mice. Neurosci. Res. 35 (1999) 77-83
49. Yao G.L., Tohyama M., and Senba E. Histamine-caused itch induces Fos-like immunoreactivity in dorsal horn neurons: effect of morphine pretreatment. Brain Res. 599 (1992) 333-337
50. Zhang R.X., Mi Z.P., and Qiao J.T. Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul. Pept. 51 (1994) 25-32